Corpus Intelligence IC Memo — MACON COUNTY GENERAL HOSPITAL 2026-04-27 02:42 UTC
IC Memo — MACON COUNTY GENERAL HOSPITAL
Investment Committee Memorandum | TN | 25 beds | Grade D | EBITDA uplift $1.4M
🛡️ Public data only — no PHI permitted on this instance.
INVESTMENT COMMITTEE MEMORANDUM  ·  CCN 441305

MACON COUNTY GENERAL HOSPITAL

LOCATIONMACON, TN·BEDS25·AS OFApril 27, 2026
D
INVESTABILITY
EBITDA BridgeData Room

1. Target Overview & Investment Thesis

MACON COUNTY GENERAL HOSPITAL is a 25-bed rural/critical access in MACON, TN with $18.7M in net patient revenue and a -0.4% operating margin. The hospital serves a payer mix of 55.0% Medicare, 5.3% Medicaid, and 39.8% commercial.

Thesis: Turnaround. Our ML models identify $1.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -0.4% to 6.9% (+736bps).

Net Revenue HCRIS$18.7M
Current EBITDA COMPUTED$-79K
Operating Margin COMPUTED-0.4%
Occupancy HCRIS37.1%
Revenue / Bed COMPUTED$747K
Net-to-Gross HCRIS34.0%
Distress Probability ML53.4%

2. Market Context & Competitive Position

141
TN Hospitals
-0.6%
State Median Margin
55
Comparable Hospitals

TN has 141 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of -0.4% places it above the state median. Among 55 size-comparable peers (12-50 beds), the median margin is -0.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 55 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MACON COUNTY GENERAL HOSPITAL (Target)TN25$18.7M-0.4%
BAPTIST MEM HOSPITAL TIPTON COTN48$179.0M-5.8%
INDIAN PATH COMMUNITY HOSPITALTN35$142.8M12.0%
HENRY COUNTY MEDICAL CENTERTN43$81.7M-13.0%
THE CENTER FOR SPINAL SURGERYTN23$78.7M39.3%
TRUSTPOINT HOSPITALTN18$50.8M-0.8%
BAPTIST MEM HOSPITAL UNION CITTN43$50.5M5.1%
VANDERBILT BEDFORD COUNTY HOSPTN24$49.5M1.9%
NEWPORT MEDICAL CENTERTN32$47.8M11.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$392K+210bp18mo
Cost to Collect4.5%2.5%$373K+200bp12mo
Denial Rate Reduction12.0%6.5%$370K+198bp12mo
A/R Days Reduction5200.0%3800.0%$227K+122bp9mo
Clean Claim Rate88.0%96.0%$12K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$392K
Cost to Collect
$373K
Denial Rate Reduction
$370K
A/R Days Reduction
$227K
Clean Claim Rate
$12K
Total EBITDA Uplift$1.4M
Current EBITDA$-79K
+ RCM Uplift+$1.4M
Pro Forma EBITDA$1.3M
Current Margin-0.4%
Pro Forma Margin6.9%
WC Released (1x)$716K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-121K$13.2M0.00x-100.0%
Base (11x exit)10.0x11.0x$-121K$14.5M0.00x-100.0%
Bull Case9.0x11.0x$-109K$19.0M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-109K$20.7M0.00x-100.0%
Bear Case11.0x10.0x$-133K$6.4M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-133K$7.0M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
HighElevated distress probabilityModel estimates 53.4% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 55 hospitals with 12-50 beds
  • Same-state prioritization (n=56)
  • Comp margins: P25=-14.4% / P50=-0.8% / P75=9.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 27, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.